NEW YORK (Reuters Health) – Active surveillance of prostate cancer, with intervention offered for progressive disease, appears to be safe even for intermediate-risk disease in men over the…
NEW YORK (Reuters Health) – New research confirms that tubular carcinoma (TC) of the breast has an excellent prognosis and goes on to show that outcomes are better…
NEW YORK (Reuters Health) – Transfusion of two rather than one unit of partially HLA-matched umbilical cord blood (UCB) appears to reduce the risk of relapse in leukemia…
Power of Pink is an initiative by Brighton Collectibles to raise money to support women suffering from breast cancer. Brighton Collectibles raises money by selling a Power of…
The Power of Pink is an initiative by Brighton Collectible to raise money to assist women with breast cancer. The program focuses on providing education and support for…
NEW YORK (Reuters Health) – In an update to its 2003 guidelines for stage IV non-small-cell lung cancer (NSCLC) chemotherapy, the American Society of Clinical Oncology (ASCO) recommends…
NEW YORK (Reuters Health) – In an update to its 2002 guidelines, the US Preventive Services Task Force (USPSTF) is now recommending that mammographic screening for breast cancer…
NEW YORK (Reuters Health) – After breast-conserving surgery for invasive cancer, mammographic density is a risk factor for local recurrence, particularly in women who don’t undergo radiotherapy, investigators…
NEW YORK (Reuters Health) – In patients with locoregionally advanced squamous-cell carcinoma of the head and neck (LASCCHN), the survival benefit of adding cetuximab to radiotherapy is still…
NEW YORK (Reuters Health) – In women treated for small (1 cm or less), node-negative breast cancers, HER2 positivity is strongly linked to recurrence and poorer disease-free survival,…